| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/23/2004 | CA2526166A1 Blood flow estimates through replenishment curve fitting in ultrasound contrast imaging |
| 12/23/2004 | CA2494704A1 Radioactively labelled amino acid analogues, their preparation and use |
| 12/22/2004 | EP1489134A1 X-ray detectable fiber and medical absorbent gauze including the same |
| 12/22/2004 | EP1487762A1 Radiofluorination methods |
| 12/22/2004 | EP1487500A1 Monitoring marker |
| 12/22/2004 | EP1487499A2 Contrast agents for magnetic resonance imaging and methods related thereto |
| 12/22/2004 | EP1487345A1 Device and method for quantifying bodies by means of ultrasound |
| 12/22/2004 | EP1487343A1 Biospecific contrast agents |
| 12/22/2004 | EP1487334A1 Paramagnetic particles that provide improved relaxivity |
| 12/22/2004 | EP1487331A1 Diagnosis marker |
| 12/22/2004 | EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 12/22/2004 | EP1154990B1 Phthalamide-lanthanide complexes for use as luminescent markers |
| 12/22/2004 | EP0799045B2 Treatment of hyperexcited nerve cell functions |
| 12/21/2004 | US6833478 N,N-dinitramide salts as solubilizing agents for biologically active agents |
| 12/21/2004 | US6833128 Transferring temporary tattoo to skin; calibrating response |
| 12/16/2004 | WO2004109181A2 Device having a location for holding hyperpolarized inert gas |
| 12/16/2004 | WO2004108902A2 Biocompatible fluorescent silicon nanoparticles |
| 12/16/2004 | WO2004108747A2 Lectin conjugates |
| 12/16/2004 | WO2004108165A2 Magnetic nanoparticles linked to a lingand |
| 12/16/2004 | WO2004108070A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/16/2004 | WO2004107987A1 Method and apparatus for measuring concentration of substance in living body |
| 12/16/2004 | WO2004089072A3 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 12/16/2004 | WO2004081574A3 Detection, monitoring and treatment of cancer |
| 12/16/2004 | WO2004081198A3 Methods for modulating angiogenesis with apelin compositions |
| 12/16/2004 | WO2003104799A3 Imaging method and device for carrying out said method |
| 12/16/2004 | US20040255344 Rodent with urinary disturbance and method of constructing the same, and method of screening remedy for urinary disturbance using the rodent |
| 12/16/2004 | US20040254372 Poly(adenosine 5'-diphospho-ribose)polymerase (PARP) inhibitor; for treating or preventing neurological, genetic, autoimmune, nervous system, cardiovascular disorders, cancer; such as myocardial infarction, angina pectoris and cardiogenic shock |
| 12/16/2004 | US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders |
| 12/16/2004 | US20040254339 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
| 12/16/2004 | US20040254154 Prediction of changes to visual acuity from assessment of macular edema |
| 12/16/2004 | US20040253292 MR-signal emitting coatings |
| 12/16/2004 | US20040253184 Lipid containing hydrophilic head group comprising lanthanide-diethylenetriamine pentaacetic acid chelate, linker group is selected from polyethylene glycol, propylene glycol, and polyglycines; imaging enhancement |
| 12/16/2004 | US20040253183 Apparatus, system and method for generating bubbles on demand |
| 12/16/2004 | US20040253182 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 12/16/2004 | US20040253181 Novel compositions magnetic particles covered with gem-bisphosphonate derivatives |
| 12/16/2004 | US20040253179 Monitoring tolerances in patients by infusing dietary formula into the stomach, measuring/evaluating aspirated gastric residual volume; Brix values |
| 12/16/2004 | CA2528136A1 Transfection agents |
| 12/16/2004 | CA2526007A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/15/2004 | EP1486785A1 Test agents for evaluating pharmacological effect of drug, and method and reagents for screening drug having excellent administration effect and/or little side effect from among drugs comprising enzymes, enzyme inhibitors or receptor ligands and/or produrgs thereof |
| 12/15/2004 | EP1486211A1 Compositions for treating cancer using viruses |
| 12/15/2004 | EP1485716A1 Optical imaging probes |
| 12/15/2004 | EP1485075A2 Mhc-peptide complex binding ligands |
| 12/15/2004 | CN1555253A Oily composition of taxol,preparation for chemical therapeutic embolism and their producing method |
| 12/14/2004 | US6830894 Compounds and methods for modulating claudin-mediated functions |
| 12/14/2004 | US6830743 In Vivo stain compounds and methods of use to identify dysplastic tissue |
| 12/14/2004 | CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis |
| 12/13/2004 | CA2468651A1 Detection of neurodegenerative diseases |
| 12/09/2004 | WO2004107368A2 Ferrofluids stable in neutral media and ferrofluids employing surface-modified particles |
| 12/09/2004 | WO2004105803A1 Marker or filler forming fluid for use in biopsy procedures |
| 12/09/2004 | WO2004105802A1 Tracer for medical imaging |
| 12/09/2004 | WO2004105801A1 Animal model for the alleviation of pain using il-6 |
| 12/09/2004 | WO2004058703A3 Methods of identifying longevity modulators and therapeutic methods of use thereof |
| 12/09/2004 | WO2004058275A3 Compositions of magnetic particles covered with gem-bisphosphonate derivatives |
| 12/09/2004 | WO2004042074A3 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein |
| 12/09/2004 | WO2004005531A3 Targeting and tracking of cells to specific organs and tissues in vivo |
| 12/09/2004 | WO2003101486A3 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 12/09/2004 | WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies |
| 12/09/2004 | US20040249317 Increasing retrievable cells from a breast duct |
| 12/09/2004 | US20040249274 Polarized light imaging devices and methods |
| 12/09/2004 | US20040248856 Chelating agents with lipophilic carriers |
| 12/09/2004 | US20040248251 Receptors and membrane associated proteins |
| 12/09/2004 | US20040248062 Material for differently modifying the optical properties of different cells |
| 12/09/2004 | US20040248061 Material for differently modifying the optical properties of different cells |
| 12/09/2004 | US20040248058 Material for differently modifying the optical properties of different cells |
| 12/09/2004 | US20040247695 Light-stabilized $I(in vivo) stain composition and method of manufacture |
| 12/09/2004 | US20040247623 Method and article for treatment of sensory neuron related disorders through transdermal application of botulinum toxin |
| 12/09/2004 | US20040247608 The hapten moieties are attached, directly or indirectly, to lysines of the monomeric units of the carrier; particularly an aggregated STn-KLH conjugate; used particularly for cancer immunotherapy |
| 12/09/2004 | US20040247527 Incorporating a targeting moiety, a photodynamic therapy moiety (especially a two photon absorber), and a medical imaging agent (such as a chromophore, contrast agent, etc.). |
| 12/09/2004 | US20040247525 Brain progenitor cell-based assay, and related methods and compositions |
| 12/09/2004 | US20040247524 Method of treatment of an inflammatory disorder with a Vanin-1 antagonist |
| 12/09/2004 | CA2526967A1 Ferrofluids stable in neutral media and ferrofluids modified obtained by modifying the modifying of surface particles of these ferrofluids |
| 12/08/2004 | EP1483580A2 Biomarker for efficacy of appetite suppressant drugs |
| 12/08/2004 | EP1483579A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 12/08/2004 | EP1483561A2 Light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 12/08/2004 | EP1483399A2 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| 12/08/2004 | EP1483277A2 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 12/08/2004 | EP1483262A1 Coumarines useful as biomarkers |
| 12/08/2004 | EP1483237A2 Tropane compounds |
| 12/08/2004 | EP1482986A1 Method for determining effect of a clostridial toxin upon a muscle |
| 12/08/2004 | EP1482985A2 Technetium-dipyridine complexes, and methods of use thereof |
| 12/08/2004 | EP1482983A2 Non-myeloablative tolerogenic treatment with tyrphostins |
| 12/08/2004 | EP1482981A1 Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 12/08/2004 | EP1482923A1 Process to prepare semicarbazones' and/or tiosemicarbazones' formulations using cyclodextrins and their derivatives and products obtained by this process |
| 12/08/2004 | EP1482795A1 New immunoeffector compounds |
| 12/08/2004 | CN1554028A A method of using spectral-spatial exitation at magnetic resonance imaging |
| 12/08/2004 | CN1552855A Vascular endothelial growth factor 2 |
| 12/08/2004 | CN1178899C Preparation of iodixanol |
| 12/08/2004 | CN1178701C Method for detecting abnormal epithelial cell shedding |
| 12/07/2004 | US6828471 Immune defective rodent for use in the classification, evaluation and treatment of cancer |
| 12/07/2004 | US6827927 Preparation of racemic mixture of gadolinium complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(2-glutaric acid); acid refluxing solution containing RRRR and SSSS stereoisomers |
| 12/07/2004 | US6827926 Administering a porphyrin compound that coordinates gallium in the central pyrrolic core, and irradiating porphyrin compound with energy at a wavelength capable of exciting the molecule to achieve the desired detection or therapeutic effect |
| 12/02/2004 | WO2004103269A2 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia |
| 12/02/2004 | WO2004103183A2 Ultrasound coupling medium for use in medical diagnostics |
| 12/02/2004 | WO2004103164A2 Method and apparatus for homeopathic provings and diagnosis |
| 12/02/2004 | WO2003011106A3 Internal image antibodies for optical imaging and therapy |
| 12/02/2004 | US20040242854 Marking proteins/peptides for solid phase synthesis; proteomics |
| 12/02/2004 | US20040242852 Bifunctional chelating agent for actinium |
| 12/02/2004 | US20040241855 Polyoxyethylene glycol (peg)-lipid-immunogen conjugates; for incorporation into liposomes to enhance intracelllar delivery of nucleic acids and drugs |
| 12/02/2004 | US20040241811 Enzymatic method of producing 4-O-B-D-galactopyranosyl-D-xylose, 4-O-B-D-galactopyranosyl-D-xylose obtained using said method, compositions contain same and the use thereof in evaluating intestinal lactase |
| 12/02/2004 | US20040241760 Kinesin-like proteins and methods of use |